- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Cost per beneficiary of select drugs in Canada's public drug plans 2017-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Cost per beneficiary of select drugs in Canada's public drug plans 2017-2018
Average cost per beneficiary of select prominent drugs in Canada's public drug plans in 2017/2018 (in Canadian dollars)*
by Matej Mikulic,
last edited
Sep 9, 2019
As of fiscal year 2017/2018, prescription drug Janumet (with the ingredients sitagliptin and metformin) cost, on average, about 968 Canadian dollars per beneficiary. Janumet is a widely used medicine to treat type 2 diabetes.
Average cost per beneficiary of select prominent drugs in Canada's public drug plans in 2017/2018 (in Canadian dollars)*
| Average cost in Canadian dollars per prescription | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Average cost in Canadian dollars per prescription | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Sep 9, 2019
As of fiscal year 2017/2018, prescription drug Janumet (with the ingredients sitagliptin and metformin) cost, on average, about 968 Canadian dollars per beneficiary. Janumet is a widely used medicine to treat type 2 diabetes.
- Show sources information
- Show publisher information
- Release date
- 2019
- Region
- Canada
- Survey time period
- FY 2017/2018
- Supplementary notes
-
* The public drug plans include British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick,
Nova Scotia, Prince Edward Island, Newfoundland and Labrador, and the Non-Insured Health Benefits Program.
This analysis only includes data for beneficiaries that met their deductible and received public reimbursement.
Source
- Show sources information
- Show publisher information
- Release date
- 2019
More information
- Region
- Canada
- Survey time period
- FY 2017/2018
- Supplementary notes
-
* The public drug plans include British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick,
Nova Scotia, Prince Edward Island, Newfoundland and Labrador, and the Non-Insured Health Benefits Program.
This analysis only includes data for beneficiaries that met their deductible and received public reimbursement.
Other statistics on the topic
+Pharmaceutical Products & Market
Top pharmaceutical companies located in Canada in 2017, by revenue
+Pharmaceutical Products & Market
Pharmaceutical spending per capita in selected countries 2018
+Pharmaceutical Products & Market
Leading countries in life sciences sector M&As 2019
+Pharmaceutical Products & Market
Top 10 global pharmaceutical markets: growth 2012-2017
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Canadian pharmaceutical industry
- 71 page/s
- English
- pptx
- Detailed references
Everything On "Canadian pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Canadian pharmaceutical industry"
- Global positioning
The most important statistics
- Market share of top 10 national pharmaceutical markets worldwide in 2017*Market share of the leading 10 global pharmaceutical markets 2017
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Pharmaceutical spending per capita in selected countries as of 2018 (in U.S. dollars)Pharmaceutical spending per capita in selected countries 2018
- Drug products sales distribution in selected countries in 2017, by therapeutic class*Drug products sales distribution worldwide by country and therapy area 2017
- Leading countries in global life sciences mergers and acquisitions based on deal number in 2019*Leading countries in life sciences sector M&As 2019
- Availability of new cancer drugs launched in 2013-2017 in selected countries as of 2018Availability of new cancer drugs by country as of 2018
- Key figures
The most important statistics
- Total health expenditure on drugs in Canada from 2005 to 2018 (in billion Canadian dollars)Health expenditures on drugs in Canada 2005-2018
- Pharmaceutical sales from patented and non-patented drugs in Canada from 2004 to 2017 (in billion Canadian dollars)Pharmaceutical sales from patented and non-patented drugs in Canada 2004-2017
- Total pharmaceutical R&D expenditures in Canada from 2004 to 2017 (in billion Canadian dollars)Spending on R&D from pharmaceutical industry in Canada 2004-2017
- Employment in Canadian pharmaceutical industry manufacturing from 2005 to 2018*Employment in pharmaceutical manufacturing in Canada 2005-2018
- Top 10 pharmaceutical companies in Canada in 2017, by revenue (in billion Canadian dollars)Top pharmaceutical companies located in Canada in 2017, by revenue
- Pharmaceutical trade balance of Canada from 2004 to 2018 (in billion Canadian dollars)Pharmaceutical industry trade balance of Canada 2004-2018
- Regional comparison
The most important statistics
- Prescription drug expenditure in Canada by public drug plan in 2017/2018 (in million Canadian dollars)Prescription drug expenditure in Canada by public drug plan 2017/2018
- Distribution of current pharmaceutical R&D expenditures in Canada as of 2017, by region*Pharmaceutical current R&D spending distribution in Canada by region 2017
- Drug expenditure per capita in Canada by province in 2018 (in Canadian dollars)*Medication spending per capita in Canada by province 2018
- Generic share of total number of prescriptions in Canada by province in 2018Provincial generic medicine prescription market share in Canada 2018
- Employees in the pharmaceutical industry in Canada as of 2016, by provincePharmaceutical industry jobs in Canada by province 2016
- Average salary in Canada's pharmaceutical industry as of 2016, by province (in Canadian dollars)Pharmaceutical industry salary in Canada by province 2016
- Generics
The most important statistics
- Canadian prescribed generic medicine sales from 2006 to 2018 (in billion Canadian dollars)Generic Rx medicine sales in Canada 2006-2018
- Canadian generic and brand name medicine average retail price per prescription from 2004 to 2018 (in Canadian dollars)*Generic and brand name medicine average retail price in Canada 2004-2018
- Generic share of medicine prescriptions in Canada from 2006 to 2018Generic medicine prescription market share in Canada 2006-2018
- Generics share of prescribed drug costs in Canada from 2006 to 2018Generic medicine share of Canada's prescription costs 2006-2018
- Total generic drug savings in Canada in 2017, by province (in million Canadian dollars)Total generic drug savings Canada 2017, by province
- Private and public generic drug savings in Canada in 2017, by province (in million Canadian dollars)Private and public generic drug savings Canada 2017, by province
- Products and prices
The most important statistics
- Top 10 pharmaceutical products in Canada in 2017, by revenue (in million Canadian dollars)Top pharmaceutical products in Canada by revenue 2017
- Average cost per beneficiary of select prominent drugs in Canada's public drug plans in 2017/2018 (in Canadian dollars)*Cost per beneficiary of select drugs in Canada's public drug plans 2017-2018
- Top biologic drugs by share of total drug costs within select Canadian public drug plans in 2017/2018*Top biologic drugs by share of total drug costs in Canadian public plans 2017-2018
- Costs of biologic drugs in select Canadian public drug plans in 2017/2018 (in million Canadian dollars)Biologic drug costs in select Canadian public drug plans in 2017/2018
- Patented drugs price index changes in Canada from 1988 to 2017*Changes in price index of patented drugs in Canada 1988-2017
- Average foreign-to-Canadian price ratio for patented drugs as of 2017Average price ratio Canadian to foreign drug prices 2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Active beneficiary population change in Canadian public drug plans 2017/2018
- Dispensing fee per prescription in Canada by drug plan 2017/2018
- Average day supply per prescription in Canada by public drug plan 2017/2018
- Biologics share of total drug costs in Canada by public drug plan 2017/2018
- Level 1 ATC therapy classes by share of total public drug costs in Canada 2017/2018
- Rates of change in dispensing costs in Canada by public drug plan 2015-2018
- Generic drugs average unit cost index in Canada by public drug plan 2013/2014
- Unit number per prescription in Canada's public drug plans 2013/2014
- Growth in prescriptions of select drugs in Canada's public drug plans 2013/2014
- Rx drug expenditure in Canada by plan and type 2017/2018
- Average Rx drug cost per senior beneficiary in Canada by public drug plan 2015/2016
- Drug dispensing cost share by drug type in public drug plans Canada 2014/15-2015/16
- Share of drug dispensing costs in select public drug plans Canada 2015-2018
- Change of drug cost in Canada by public drug plan 2017/2018
- Senior and non-senior beneficiaries share in Canada by public drug plan 2017/2018
- Total U.S. Federal Bureau of Investigation outlays 2010-2020
- Italy: opinion on public investments in the national healthcare system 2018-2019
- Public drug plan beneficiaries in Canada as share of total population 2017-2018
- Health program outlays by other defense civil programs in the U.S. 2010-2020
- Italy: share of users satisfied with the national health system 2018-2019
Studies
- Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2...
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015
- Compass Rx - Annual Public Drug Plan Expenditure Report 2012/13
- Prescription Cost Analysis, England 2018
- The Oregon Medical Marijuana Program (April 2019)
- Compass Rx - Annual Public Drug Plan Expenditure Report 2013/14
- Compass Rx - Annual Public Drug Plan Expenditure Report 2015/16
- Prescribed Drug Spending in Canada, 2018
- Drug Use Among Seniors in Canada, 2016
- The Oregon Medical Marijuana Program (April 2018)
- Antibiotic use in the United Kingdom (UK)
- Prescription Cost Analysis, England 2014
- Prescribed Drug Spending in Canada, 2017
- Meds Entry Watch 2017
- Prescription Cost Analysis, England 2015
Statistics on "Canadian pharmaceutical industry"
- Market share of top 10 national pharmaceutical markets worldwide in 2017*
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*
- Pharmaceutical spending per capita in selected countries as of 2018 (in U.S. dollars)
- Drug products sales distribution in selected countries in 2017, by therapeutic class*
- Leading countries in global life sciences mergers and acquisitions based on deal number in 2019*
- Availability of new cancer drugs launched in 2013-2017 in selected countries as of 2018
- Total health expenditure on drugs in Canada from 2005 to 2018 (in billion Canadian dollars)
- Pharmaceutical sales from patented and non-patented drugs in Canada from 2004 to 2017 (in billion Canadian dollars)
- Total pharmaceutical R&D expenditures in Canada from 2004 to 2017 (in billion Canadian dollars)
- Employment in Canadian pharmaceutical industry manufacturing from 2005 to 2018*
- Top 10 pharmaceutical companies in Canada in 2017, by revenue (in billion Canadian dollars)
- Pharmaceutical trade balance of Canada from 2004 to 2018 (in billion Canadian dollars)
- Prescription drug expenditure in Canada by public drug plan in 2017/2018 (in million Canadian dollars)
- Distribution of current pharmaceutical R&D expenditures in Canada as of 2017, by region*
- Drug expenditure per capita in Canada by province in 2018 (in Canadian dollars)*
- Generic share of total number of prescriptions in Canada by province in 2018
- Employees in the pharmaceutical industry in Canada as of 2016, by province
- Average salary in Canada's pharmaceutical industry as of 2016, by province (in Canadian dollars)
- Canadian prescribed generic medicine sales from 2006 to 2018 (in billion Canadian dollars)
- Canadian generic and brand name medicine average retail price per prescription from 2004 to 2018 (in Canadian dollars)*
- Generic share of medicine prescriptions in Canada from 2006 to 2018
- Generics share of prescribed drug costs in Canada from 2006 to 2018
- Total generic drug savings in Canada in 2017, by province (in million Canadian dollars)
- Private and public generic drug savings in Canada in 2017, by province (in million Canadian dollars)
- Top 10 pharmaceutical products in Canada in 2017, by revenue (in million Canadian dollars)
- Average cost per beneficiary of select prominent drugs in Canada's public drug plans in 2017/2018 (in Canadian dollars)*
- Top biologic drugs by share of total drug costs within select Canadian public drug plans in 2017/2018*
- Costs of biologic drugs in select Canadian public drug plans in 2017/2018 (in million Canadian dollars)
- Patented drugs price index changes in Canada from 1988 to 2017*
- Average foreign-to-Canadian price ratio for patented drugs as of 2017
- Change in active beneficiary population in select Canadian public drug plans in 2017/2018 compared to previous year
- Average dispensing fee per prescription in select Canadian public drug plans in 2013/2014 and 2017/2018 (in Canadian dollars)
- Average day supply per prescription in select Canadian public drug plans in 2017/2018
- Biologic share of total drug costs in select Canadian public drug plans in 2017/2018
- Leading level 1 ATC therapeutic classes by share of total drug costs in select Canadian public drug plans in 2017/2018*
- Annual rates of change in drug dispensing costs in Canada by public drug plan from FY 2015/16 to FY 2017/18
- Average unit cost index for generic drugs in Canada by public drug plan from 2009/2010 to 2013/2014
- Average number of units per prescription in select Canadian public drug plans in 2013/2014
- Growth in prescriptions of select prominent drugs in Canada's public drug plans in 2013/2014 compared to 2012/2013*
- Prescription drug expenditure in Canada by public drug plan and type in 2017/2018 (in million Canadian dollars)
- Annual average prescription drug cost per senior beneficiary in Canada by public drug plan in FY 2015/2016 (in Canadian dollars)*
- Distribution of drug dispensing costs by drug type in select public Canadian drug plans as of FY 2015/16*
- Dispensing costs as share of total Rx drug costs in select public drug plans in Canada from 2015/2016 to 2017/2018
- Change of drug costs in selected Canadian public drug plans in 2017/2018 compared to previous year
- Distribution of senior and non-senior active beneficiaries in select Canadian public drug plans in 2017/2018
- Total U.S. Federal Bureau of Investigation outlays including health programs from 2010 to 2020 (in million U.S. dollars)
- Share of people who consider useful to invest in the national healthcare system in Italy in 2018 and 2019
- Active public drug plan beneficiaries in Canada as a share of total population by province in 2017/2018
- Health program outlays by other defense civil programs in the U.S. from 2010 to 2020 (in million U.S. dollars)
- Share of users satisfied with the national health system in Italy in 2018 and 2019
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.